Atalanta Sosnoff Capital Increased Roper Technologies (ROP) Stake By $13.79 Million; CareDx (CDNA)’s Sentiment Is 6.14

April 10, 2018 - By Martha Paddon

Roper Technologies, Inc. (NYSE:ROP) Logo

Atalanta Sosnoff Capital Llc increased Roper Technologies Inc (ROP) stake by 46.56% reported in 2017Q4 SEC filing. Atalanta Sosnoff Capital Llc acquired 53,464 shares as Roper Technologies Inc (ROP)’s stock rose 6.89%. The Atalanta Sosnoff Capital Llc holds 168,294 shares with $43.59 million value, up from 114,830 last quarter. Roper Technologies Inc now has $27.57 billion valuation. The stock increased 0.09% or $0.24 during the last trading session, reaching $268.08. About 625,550 shares traded or 28.83% up from the average. Roper Technologies, Inc. (NYSE:ROP) has risen 35.33% since April 10, 2017 and is uptrending. It has outperformed by 23.78% the S&P500.

CareDx (CDNA) investors sentiment increased to 6.14 in Q4 2017. It’s up 4.26, from 1.88 in 2017Q3. The ratio is better, as 43 investment professionals started new and increased equity positions, while 7 sold and trimmed positions in CareDx. The investment professionals in our database now hold: 27.90 million shares, up from 6.43 million shares in 2017Q3. Also, the number of investment professionals holding CareDx in top ten equity positions increased from 1 to 4 for an increase of 3. Sold All: 3 Reduced: 4 Increased: 13 New Position: 30.

Investors sentiment decreased to 0.96 in 2017 Q4. Its down 0.32, from 1.28 in 2017Q3. It is negative, as 32 investors sold ROP shares while 212 reduced holdings. 62 funds opened positions while 173 raised stakes. 95.52 million shares or 3.45% less from 98.93 million shares in 2017Q3 were reported. Korea Invest accumulated 115,342 shares or 0.14% of the stock. Trexquant Investment Limited Partnership holds 0.11% of its portfolio in Roper Technologies, Inc. (NYSE:ROP) for 3,809 shares. Chesley Taft & Limited Liability holds 0.19% or 8,645 shares. 262,087 were reported by Dimensional Fund L P. Greenleaf has invested 0.21% in Roper Technologies, Inc. (NYSE:ROP). Washington Tru holds 13,269 shares or 0.19% of its portfolio. 9,470 are held by Mount Lucas Ltd Partnership. Texas-based Stephens Investment Mgmt Grp Limited Liability Company has invested 0.07% in Roper Technologies, Inc. (NYSE:ROP). Advisor Ptnrs Lc has 1,835 shares. Moreover, First Trust Advsrs Lp has 0.1% invested in Roper Technologies, Inc. (NYSE:ROP). Metropolitan Life Ins Ny holds 19,879 shares or 0.07% of its portfolio. Country Tru Bankshares holds 75,491 shares. Proshare Advsr Limited holds 14,313 shares or 0.03% of its portfolio. Cibc Markets Corporation owns 43,921 shares for 0.08% of their portfolio. 8,580 were reported by Sawgrass Asset Mgmt Ltd.

Atalanta Sosnoff Capital Llc decreased Marsh & Mclennan Cos Inc (NYSE:MMC) stake by 7,818 shares to 282,500 valued at $22.99 million in 2017Q4. It also reduced Pepsico Inc (NYSE:PEP) stake by 8,161 shares and now owns 275,242 shares. Fedex Corp (NYSE:FDX) was reduced too.

Among 13 analysts covering Roper Industries Inc. (NYSE:ROP), 10 have Buy rating, 0 Sell and 3 Hold. Therefore 77% are positive. Roper Industries Inc. has $330.0 highest and $150 lowest target. $278.18’s average target is 3.77% above currents $268.08 stock price. Roper Industries Inc. had 53 analyst reports since July 29, 2015 according to SRatingsIntel. JP Morgan downgraded the stock to “Underweight” rating in Friday, September 11 report. RBC Capital Markets maintained Roper Technologies, Inc. (NYSE:ROP) on Tuesday, November 1 with “Outperform” rating. The firm has “Outperform” rating given on Tuesday, October 27 by RBC Capital Markets. Stifel Nicolaus maintained the stock with “Buy” rating in Sunday, December 10 report. The stock has “Overweight” rating by JP Morgan on Friday, January 13. The stock has “Buy” rating by Stifel Nicolaus on Wednesday, November 25. The rating was upgraded by Zacks to “Sell” on Thursday, August 20. The stock of Roper Technologies, Inc. (NYSE:ROP) earned “Neutral” rating by JP Morgan on Friday, March 24. The rating was upgraded by Oppenheimer to “Outperform” on Friday, January 6. The rating was maintained by RBC Capital Markets with “Buy” on Monday, July 10.

Since October 31, 2017, it had 1 buying transaction, and 7 insider sales for $103.28 million activity. Shares for $1.04M were sold by KNOWLING ROBERT E JR on Tuesday, October 31. JELLISON BRIAN D had sold 74,589 shares worth $20.66 million. $141,295 worth of stock was bought by WALLMAN RICHARD F on Monday, March 12. The insider WRIGHT CHRISTOPHER sold $420,120. JOHNSON ROBERT D had sold 1,000 shares worth $283,450 on Monday, March 12.

The stock increased 2.23% or $0.19 during the last trading session, reaching $8.72. About 511,566 shares traded or 58.15% up from the average. CareDx, Inc (CDNA) has risen 402.58% since April 10, 2017 and is uptrending. It has outperformed by 391.03% the S&P500.

CareDx, Inc., together with its subsidiaries, focuses on the discovery, development, and commercialization of diagnostic surveillance solutions for transplant patients in North America, Europe, the Middle East, Africa, and Latin America. The company has market cap of $253.53 million. The firm operates through two divisions, CareDx and Olerup. It currently has negative earnings. The Company’s commercialized testing solution includes the AlloMap heart transplant molecular test , a gene expression test that helps clinicians monitor and identify heart transplant recipients with stable graft function who have a low probability of moderate/severe acute cellular rejection.

Since January 1, 0001, it had 0 insider purchases, and 1 sale for $118,035 activity.

Paragon Associates & Paragon Associates Ii Joint Venture holds 5.79% of its portfolio in CareDx, Inc for 948,000 shares. Gagnon Advisors Llc owns 955,758 shares or 5.14% of their US portfolio. Moreover, Gagnon Securities Llc has 4.89% invested in the company for 1.88 million shares. The Virginia-based Thompson Davis & Co. Inc. has invested 3.63% in the stock. Perkins Capital Management Inc, a Minnesota-based fund reported 178,639 shares.

CareDx, Inc (NASDAQ:CDNA) Institutional Positions Chart